Literature DB >> 11994569

Retinal artery occlusion in a patient with factor V Leiden and prothrombin G20210A mutations.

R Ben-Ami1, D Zeltser, I Leibowitz, S A Berliner.   

Abstract

Retinal artery occlusion is rare in young adults, and may be associated with hereditary thrombophilia. We present a 19-year-old male who was evaluated for central retinal artery occlusion and found to be homozygous for the factor V Leiden mutation and heterozygous for the prothrombin G20210A mutation. Anterior chamber paracenthesis resulted in dramatic improvement, but recurring loss of vision necessitated repeated paracenthesis and the addition of aspirin to standard anticoagulation treatment. The literature concerning hereditary thrombophilia and retinal artery occlusion is reviewed, and the synergistic effect of multiple risk factors is emphasized. Screening for hereditary thrombophilia should be considered for young people presenting with unexplained retinal artery occlusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994569     DOI: 10.1097/00001721-200201000-00009

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  3 in total

1.  Thrombophilic screening in retinal artery occlusion patients.

Authors:  Valeria Nagy; Lili Takacs; Zita Steiber; György Pfliegler; Andras Berta
Journal:  Clin Ophthalmol       Date:  2008-09

2.  Diagnostic ramifications of ocular vascular occlusion as a first thrombotic event associated with factor V Leiden and prothrombin gene heterozygosity.

Authors:  Samantha Schockman; Charles J Glueck; Robert K Hutchins; Jaykumar Patel; Parth Shah; Ping Wang
Journal:  Clin Ophthalmol       Date:  2015-04-03

3.  Retinal vascular occlusion: a window to diagnosis of familial and acquired thrombophilia and hypofibrinolysis, with important ramifications for pregnancy outcomes.

Authors:  Stephan G Dixon; Carl T Bruce; Charles J Glueck; Robert A Sisk; Robert K Hutchins; Vybhav Jetty; Ping Wang
Journal:  Clin Ophthalmol       Date:  2016-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.